Comparing long and short peripheral venous catheters for hospitalized patients
Comparison of Application Effects Between Long Peripheral Venous Catheters and Standard Short Peripheral Venous Catheters: A Multicenter Prospective Randomized Controlled Trial Study
This study is testing whether long or short IV catheters are better for hospitalized patients in terms of complications and overall effectiveness.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Shenzhen Third People's Hospital Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Trial ID | NCT06503822 on ClinicalTrials.gov |
What this trial studies
This study investigates the application effects of long peripheral intravenous catheters (PIVC) compared to standard short PIVC in hospitalized patients. Participants will be randomly assigned to receive either a short or long PIVC, with their catheter-related complications and overall effectiveness monitored throughout their hospital stay. The goal is to provide insights into the optimal selection of intravenous therapy tools, enhancing patient care and safety. Data collected will include demographic information, duration of therapy, and any complications related to the catheters.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients aged 18 years or older who require intravenous therapy for more than four days.
Not a fit: Patients requiring central venous access or those with certain medical conditions that interfere with catheter use may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the selection of intravenous catheters, leading to better patient outcomes and reduced complications.
How similar studies have performed: While the use of short PIVCs is well-established, the application of long PIVCs is less studied, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A male or female aged 18 years or older who is able and willing to give written informed consent; 2. Identification of the patient's medical diagnosis based on the competent physician and the study nurse at any time during the hospital stay, and judgment that the duration of peripheral intravenous infusion therapy needs to exceed 4 days; 3. Subjects with good compliance and can cooperate with catheter maintenance and observation. Exclusion Criteria: 1. Patients who are delirious and unable to cooperate; 2. Patients requiring central venous access; 3. Patients suffering from connective tissue diseases or blood diseases; 4. Patients allergic to catheters or dressings; 5. any subject in a condition deemed by the investigator to interfere with the evaluation of results or pose a health risk to the subject.
Where this trial is running
Shenzhen, Guangdong
- Deng Qiuxia — Shenzhen, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Qiuxia Deng
- Email: 83762312@qq.com
- Phone: +86 0755-61222333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.